Quality Assessment of Robot Assisted Thoracic Surgical Resection of Non-small Cell Lung Cancer: Nodal Upstaging and Mediastinal Recurrence

Overview

Journal J Thorac Dis

Publisher AME Publishing Company

Specialty Pulmonary Medicine

Date 2021 Mar 15

PMID 33717532

Citations 4

Authors

Ghada M Shahin

Besir Topal

Sjaak Pouwels

Thanasie L Markou

Rody Boon

Jos A Stigt

Affiliations

Soon will be listed here.

Abstract

Background: Robot assisted thoracic surgery (RATS) is the minimally invasive surgical technique of choice for treatment of patients with non-small cell lung cancer (NSCLC), at the Isala Hospital. The aim of this study is to compare clinical and pathological staging results and mediastinal recurrence after RATS for anatomical resections of lung cancer as surrogate markers for quality of mediastinal lymph node dissection (MLND).

Methods: This single institute retrospective study was conducted in patients who underwent RATS for NSCLC. Excluded were patients with a history of concurrent malignant disease, with other previous neoplasms, with small cell lung cancer (SCLC) and patients in whom the robotic technique was converted to thoracotomy, prior to lymph node dissection. Data were obtained from the hospital database. The difference between clinical and pathological staging was expressed as upstaging and downstaging. Computed Tomography scanning was used for follow-up, and diagnosis of mediastinal recurrence.

Results: From November 2011 to May 2016, 227 patients underwent RATS at Isala Hospital Zwolle, the Netherlands. Of those, 130 (mean age, 69.5±9.3 years) met the eligibility criteria. Preoperative mediastinal lymph node staging was done by endoscopic ultrasound/endobronchial ultrasound, by positron emission tomography (PET) or mediastinoscopy. In 14 patients (10.8%) unforeseen N2 disease was found, 6 patients (4.6%) were upstaged from cN0 to pN2 and 8 patients (6.2%) were upstaged from cN1 to pN2. Mediastinal recurrence was detected in 7 patients (5.4%) during a median follow-up of 54 months (range, 1.5-102 months).

Conclusions: In patients with NSCLC, who underwent anatomical resection by means of RATS, an unforeseen N2 disease rate of 10.8% was demonstrated and a mediastinal recurrence rate of 5.4%. It is concluded that robotic surgery provides an accurate lymph node dissection.

Citing Articles

Safety and feasibility of robotic-assisted thoracic surgery after neoadjuvant chemoimmunotherapy in non-small cell lung cancer.

Zeng J, Yi B, Chang R, Chen Y, Yu Z, Gao Y Front Oncol. 2023; 13:1134713.

PMID: 36910671 PMC: 9996108. DOI: 10.3389/fonc.2023.1134713.

Comparison of the perioperative outcomes between robotic-assisted thoracic surgery and video-assisted thoracic surgery in non-small cell lung cancer patients with different body mass index ranges.

Qu C, Li R, Ma Z, Han J, Yue W, Aigner C Transl Lung Cancer Res. 2022; 11(6):1108-1118.

PMID: 35832453 PMC: 9271441. DOI: 10.21037/tlcr-22-137.

Oncological Outcomes of Robotic Lobectomy and Radical Lymphadenectomy for Early-Stage Non-Small Cell Lung Cancer.

Gallina F, Taje R, Forcella D, Corzani F, Cerasoli V, Visca P J Clin Med. 2022; 11(8).

PMID: 35456265 PMC: 9025272. DOI: 10.3390/jcm11082173.

Lung Cancer Surgery after Neoadjuvant Immunotherapy.

Stefani D, Plones T, Viehof J, Darwiche K, Stuschke M, Schuler M Cancers (Basel). 2021; 13(16).

PMID: 34439187 PMC: 8393473. DOI: 10.3390/cancers13164033.

References

Mahtabifard A, DeArmond D, Fuller C, McKenna Jr R . Video-assisted thoracoscopic surgery lobectomy for stage I lung cancer. Thorac Surg Clin. 2007; 17(2):223-31. DOI: 10.1016/j.thorsurg.2007.03.019. View

Haruki T, Miwa K, Araki K, Taniguchi Y, Nakamura H . Distribution and Prevalence of Locoregional Recurrence after Video-Assisted Thoracoscopic Surgery for Primary Lung Cancer. Thorac Cardiovasc Surg. 2015; 64(6):526-32. DOI: 10.1055/s-0035-1550231. View

Isaka M, Kojima H, Takahashi S, Omae K, Ohde Y . Risk factors for local recurrence after lobectomy and lymph node dissection in patients with non-small cell lung cancer: Implications for adjuvant therapy. Lung Cancer. 2018; 115:28-33. DOI: 10.1016/j.lungcan.2017.11.014. View

De Leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R . Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014; 45(5):787-98. DOI: 10.1093/ejcts/ezu028. View

McKenna Jr R . Surgical management of primary lung cancer. Semin Oncol. 2007; 34(3):250-5. DOI: 10.1053/j.seminoncol.2007.03.006. View

Boffa D, Kosinski A, Paul S, Mitchell J, Onaitis M . Lymph node evaluation by open or video-assisted approaches in 11,500 anatomic lung cancer resections. Ann Thorac Surg. 2012; 94(2):347-53. DOI: 10.1016/j.athoracsur.2012.04.059. View

Petersen R, Gjeraa K, Jensen K, Moller L, Hansen H, Konge L . Assessment of competence in video-assisted thoracoscopic surgery lobectomy: A Danish nationwide study. J Thorac Cardiovasc Surg. 2018; 156(4):1717-1722. DOI: 10.1016/j.jtcvs.2018.04.046. View

Raman V, Yang C, Deng J, DAmico T . Surgical treatment for early stage non-small cell lung cancer. J Thorac Dis. 2018; 10(Suppl 7):S898-S904. PMC: 5945689. DOI: 10.21037/jtd.2018.01.172. View

Wilson J, Louie B, Cerfolio R, Park B, Vallieres E, Aye R . The prevalence of nodal upstaging during robotic lung resection in early stage non-small cell lung cancer. Ann Thorac Surg. 2014; 97(6):1901-6. DOI: 10.1016/j.athoracsur.2014.01.064. View

10.

Licht P, Jorgensen O, Ladegaard L, Jakobsen E . A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer. Ann Thorac Surg. 2013; 96(3):943-9. DOI: 10.1016/j.athoracsur.2013.04.011. View

11.

Ricciardi S, Zirafa C, Davini F, Melfi F . How to get the best from robotic thoracic surgery. J Thorac Dis. 2018; 10(Suppl 8):S947-S950. PMC: 5934117. DOI: 10.21037/jtd.2018.03.157. View

12.

Merritt R, Hoang C, Shrager J . Lymph node evaluation achieved by open lobectomy compared with thoracoscopic lobectomy for N0 lung cancer. Ann Thorac Surg. 2013; 96(4):1171-1177. DOI: 10.1016/j.athoracsur.2013.05.044. View

13.

Velez-Cubian F, Rodriguez K, Thau M, Moodie C, Garrett J, Fontaine J . Efficacy of lymph node dissection during robotic-assisted lobectomy for non-small cell lung cancer: retrospective review of 159 consecutive cases. J Thorac Dis. 2016; 8(9):2454-2463. PMC: 5059267. DOI: 10.21037/jtd.2016.08.25. View

14.

DAmico T, Niland J, Mamet R, Zornosa C, Dexter E, Onaitis M . Efficacy of mediastinal lymph node dissection during lobectomy for lung cancer by thoracoscopy and thoracotomy. Ann Thorac Surg. 2011; 92(1):226-31. DOI: 10.1016/j.athoracsur.2011.03.134. View

15.

Swanson S, Herndon 2nd J, DAmico T, Demmy T, McKenna Jr R, Green M . Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study. J Clin Oncol. 2007; 25(31):4993-7. DOI: 10.1200/JCO.2007.12.6649. View

16.

De Leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R . Preoperative mediastinal lymph node staging for non-small cell lung cancer: 2014 update of the 2007 ESTS guidelines. Transl Lung Cancer Res. 2015; 3(4):225-33. PMC: 4367702. DOI: 10.3978/j.issn.2218-6751.2014.08.05. View

17.

Falcoz P, Massard G . Locoregional recurrence after VATS surgery for NSCLC. J Thorac Dis. 2017; 8(12):E1694-E1696. PMC: 5227236. DOI: 10.21037/jtd.2016.12.54. View

18.

Park B . Robotic lobectomy for non-small cell lung cancer: long-term oncologic results. Thorac Surg Clin. 2014; 24(2):157-62, vi. DOI: 10.1016/j.thorsurg.2014.02.011. View

19.

Begum S, Hansen H, Papagiannopoulos K . VATS anatomic lung resections-the European experience. J Thorac Dis. 2014; 6 Suppl 2:S203-10. PMC: 4032960. DOI: 10.3978/j.issn.2072-1439.2014.05.04. View

20.

Mazzei M, Abbas A . Why comprehensive adoption of robotic assisted thoracic surgery is ideal for both simple and complex lung resections. J Thorac Dis. 2020; 12(2):70-81. PMC: 7061192. DOI: 10.21037/jtd.2020.01.22. View